Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Body Surface Potential Mapping
Premkumar, Ashvini
Phase II study of imatinib in patients with small cell lung cancer.
Human urinary bladder carcinomas express adenovirus attachment and internalization receptors.
Angiogenesis inhibition in the treatment of lung cancer.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Angiogenesis inhibition in the treatment of lung cancer.
Angiogenesis inhibition in the treatment of lung cancer. Clin Adv Hematol Oncol. 2006 Nov; 4(11 Suppl 23):1-10; quiz 11-2.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carboplatin
Carcinoma, Non-Small-Cell Lung
Clinical Trials, Phase III as Topic
Disease-Free Survival
Erlotinib Hydrochloride
Hemorrhage
Humans
Lung Neoplasms
Neovascularization, Pathologic
Paclitaxel
Protein Kinase Inhibitors
Quinazolines
Randomized Controlled Trials as Topic
Risk Factors
Survival Rate
Vascular Endothelial Growth Factor A
authors with profiles
Everett E. Vokes